Therefore, lower levels of integrated HIV-1 in purified resting CD4+ T cells isolated from HIV-1 patients treated with PI-based cART compared to HIV-1-infected patients treated with NNRTI-based cART could be critical to achieve control of infection. The gene discussed is CD4; the disease is infection.